Biopharma | April 21, 2026
Freudenberg Medical launches ISO Class 5 cleanroom, 'CleanAssure'
The cleanroom operates under stringent ISO Class 5 conditions, using ultrapure water and air systems
The cleanroom operates under stringent ISO Class 5 conditions, using ultrapure water and air systems
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
PMDA is regarded among the most stringent regulatory bodies globally
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
The company allocated €56 million to research and development for next-generation line solutions
Subscribe To Our Newsletter & Stay Updated
